Astrazeneca Plc ADR (NQ: AZN )
67.91 +0.65 (+0.97%) Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Press Releases about Astrazeneca Plc ADR
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
March 14, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 14, 2023 – USA News Group – Optimism is on the rise as the American Cancer Society is reporting that the five-year survival...
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions.
Exposures Intellectual Property Legal Regulatory
There's a Lot to Love About Mineralys' Valentine's Day IPO
February 13, 2023
MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million
Topics Initial Public Offering
Exposures Securities Market
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
January 23, 2023
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
AIRSUPRA™ (PT027) approved in the US for asthma
January 11, 2023
Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer
January 05, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following